Markers for population genetic analysis of human Plasmodia species, P. falciparum and P. vivax by Hema Joshi
J Vect Borne Dis 40, September & December 2003, pp 78–83
Markers for population genetic analysis of human Plasmodia
species, P. falciparum and P. vivax
Hema Joshi
Malaria Research Centre (ICMR), 22 Sham Nath Marg, Delhi, India; hema_joshi_mrc@yahoo.com
Present report deals with the genetic diversity existing among the field isolates of Plasmodium fal-
ciparum  and P. vivax in India. Isoenzymes and molecular markers were used to analyse field iso-
lates of P. falciparum  and  P. vivax. High level of length polymorphism was observed in repeat nu-
cleotide sequences of MSP-1, MSP-2 and GLURP in P. falciparum isolates and  CSP, GAM-1 and
MSP-3α in P. vivax isolates.  In study populations a high proportion of isolates (up to 60%) were
comprised of more than one genetically distinct parasite type—multiclonal.  Presence of identical
allelic forms of enzyme and DNA variations in different geographical areas and in different years
suggest that isolates belong to a single random mating population of P. vivax and P. falciparum.
Observed random combination of alleles in the field isolates suggest the unlinked nature of loci
studied.  Study supports the feasibility of using molecular markers for the identification of recru-
descence in P. falciparum from fresh infection.
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Malaria is a serious public health problem in India and
the entire country is endemic for malaria except areas
1800 m above sea level.  Two most prevalent human
malaria parasite species in the country are Plasmodi-
um vivax and  P. falciparum.  P. vivax is the pre-
dominant species and accounts for about 60–65% of
the cases.  Recent report has shown an increasing
trend in P. falciparum incidence including drug resis-
tant strains and also spreading into the earlier P. falci-
parum free areas1. Problem of  malaria control is be-
coming difficult day by day because of development
of resistance to choloroquine, commonly used antima-
larial in parasites, to insecticides in vectors and opera-
tional problems.  Therefore, to develop suitable and
novel control strategies against the parasite, it is im-
portant to know the extent of genetic polymorphism
existing in the parasite population.  Genetic variability
of the Plasmodium parasites has made them success-
ful against all the eradication efforts made by the hu-
man kind.  Data generated on the extent of genetic di-
versity present in P. vivax and P. falciparum popula-
tions from different regions of the country will be im-
portant for the development and testing of new drugs
and malaria vaccines.  Therefore, with an objective to
understand genetic structure and to estimate the type
and the extent of genetic diversity existing among P.
falciparum and P. vivax populations, studies on en-
zyme and gene polymorphism have been carried out in
relation to space and time. Fig. 1 shows the sites from
where isolates have been characterised.
Polymorphism at glucose phosphate isomerase (GPI),
glutamate dehydrogenase (GDH), adenosine deami-
nase (ADA) and lactate dehydrogenase (LDH) en-
zyme loci in both P. vivax and P. falciparum were
examined2–5.  DNA length polymorphism of MSP-1HEMA JOSHI :  GENETIC MARKERS OF HUMAN PLASMODIA 79
& 2 (merozoite surface proteins 1&2) and GLURP
(glutamate rich protein) in P. falciparum isolates and
CSP (circumsporozoite protein),  MSP-3α (merozo-
ite surface protein 3α) and GAM-1 (transmission
blocking candidate antigen) genes in P. vivax isolates
were examined.  Table 1 lists the polymorphic mark-
ers in Indian P. falciparum and P. vivax isolates.
Studies carried out on the isoenzymes typing of P.
vivax  and P. falciparum isolates collected from pa-
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tients using GPI, GDH, ADA and LDH systems for
the first time showed the random mating nature of P.
vivax and P. falciparum isolates in India2. Further
studies continued in relation to time and space for
both P. vivax and P. falciparum species showed high
degree of genetic diversity and identical electrophoret-
ic forms of different enzyme systems in different geo-
graphical areas. Identical allelic forms observed
among P. vivax isolates studied from Delhi in relation
to time are shown in Fig. 2. Study on isoenzymes fur-
Fig. 1 : Map showing study sites for genetic diversity in malaria parasitesJ  VECT  BORNE  DIS  40, SEPTEMBER & DECEMBER  2003 80
digoxigenin labeling systems.  GAM-1 gene has been
assayed using nested PCR amplification with specific
primers8.  P. vivax MSP-3α locus was investigated in
Indian field isolates using a combined polymerase
chain reaction and restriction fragment length poly-
morphism (PCR/RFLP) protocol9. Isolates collected
from symptomatic patients attending malaria clinic of
Malaria Research Centre, Delhi showed both size and
sequence polymorphism. Size variations of PCR am-
plified product ranged between 1.2 and 1.8 kb.
RFLP pattern with Alu I and Hha I has shown 14 and
11 alleles respectively.  Sixteen different genotype
combinations of RFLP patterns were observed in a
total of 19 isolates analysed (Fig.  3).
Above observations suggest extensive parasite diver-
sity within P. vivax population of India.  Polymorphic
nature of P. vivax isolates has also been observed in
drug response and relapse pattern studies10,11.  In
general Indian isolates of P. vivax are comprised of a
good proportion of multiclonal isolates.  Based on
isoenzymes markers upto 40% isolates were categor-
ised as multiclonal and proportion has gone up to
60% with DNA size markers.
In P. falciparum, studies carried out on length poly-
morphism MSP-1 (block II) and MSP-2 (central re-
Table   1.  Markers and polymorphism in human
Plasmodia species in India
Markers P. vivax P. falciparum
Enzyme
GPI 6 alleles 6 alleles
GDH 7 alleles 5 alleles
ADA 5 alleles 3 alleles
LDH 1 allele 1 allele
DNA
Size variations GAM-1: 9 alleles MSP-1 (block II region):
9 alleles in nested
MSP-3α : 24 alleles in 3 families –
Alu 1 : 14 alleles  RO33, MAD 20 & K1
Hha 1 : 11 alleles
MSP-2  (central region):
CSP: 3 alleles 8 alleles PCR
23 alleles in 2 families–3D7
& FC27
GLURP: 11 alleles
ther revealed no difference in the proportions of single
and multiclonal isolates during low and high transmis-
sion periods of P. vivax3–5 .
Studies on the gene polymorphism of CSP, GAM-1
and MSP-3α in Indian P. vivax isolates have re-
vealed more than two variants of CSP differing in nu-
cleotide sequences and nine size variants in GAM-1 in
isolates of Delhi.  CSP variants were detected by
PCR amplification using CSP specific primers6–7 and
hybridising with allele specific DNA probes using
Fig. 2: Allelic polymorphism in P. vivax isolates
Fig. 3: MSP-3α polymorphism in P. vivax isolates
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gion) by simple PCR assay12  have shown 18 different
genotypes (Fig.  4) among P. falciparum isolates
studies from Haryana, Delhi, Orissa and Uttar
Pradesh.  Analysis of isolates from different parts of
the country using family specific assay revealed pres-
ence of all the three families of MSP-1 namely K1,
MAD20 and RO33 and both of MSP-2—3D7 and
FC27 with prevalence of K1 and MAD20 families.
Proportional distribution of families of MSP-1 and
MSP-2 is given in Fig. 5.  About 10% of P. falci-
parum isolates were categorised as multiclonal
based on isoenzymes profile and simple PCR assay.
However, nested PCR assay13 and family specific
protocol14 increased the sensitivity of characte-
risation of isolates and high degree of polymorphism
was observed. Proportion of multiclonal isolates
among study samples was observed to be about
60%.  High degree of genetic diversity among
Indian P. falciparum isolates  has also been report-
ed earlier15,16.
In P. falciparum infection treatment failure causes re-
crudescence, which may increase the proportion of
gametocyte carriers in the population, and conse-
quently increase in the transmission risk.  Thus it is of
utmost importance for the control programme to ac-
curately identify the treatment failure (recrudescence)
infection from fresh infections.  Therefore, above
markers were assessed for the identification of fresh
infection from recrudescence  in P. falciparum posi-
tive  cases.  Paired samples collected from patients
with repeat episode of malaria on Day 0 and day of
reinfection were  analysed using nested PCR assays of
MSP-1 and MSP-2.
Isolates collected from three patients on Day 0 and
Day 14 showed different genotypes of MSP-1/MSP-
2 suggesting new infection.  However, in another two
patients, isolates collected on Day 0 and Day 14
showed same genotype of both MSP-1 and   MSP-2.
Fig. 6 shows the genotypes of paired samples.  To get
more conclusive results, analysis of more samples us-
ing more markers is proposed.
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Fig. 4: Genotypes observed in P. falciparum isolates
Fig. 5: Distribution of family groups of MSP-1 & 2 of
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In conclusion, it is summarised that Indian isolates of
P. vivax and P. falciparum exhibit high level of ge-
netic diversity in respect to GPI, GDH, ADA and
LDH enzyme systems.  High level of length polymor-
phism was also observed in repeat nucleotide se-
quences of MSP-1, MSP-2 and GLURP in P. falci-
parum isolates and  CSP, GAM-1 and MSP-3α in P.
vivax isolates.  In general a high proportion of isolates
(upto 60%) were comprised of more than one geneti-
cally distinct parasite type—multiclonal.  Presence of
identical allelic forms of enzyme and DNA variations
in different geographical areas and in different years
suggest that isolates belong to a single random mating
population of P. vivax and P. falciparum.  Observed
random combination of alleles in the field isolates sup-
port the unlinked nature of loci studied.  Study sup-
port the feasibility of using molecular markers for the
identification of recrudescence in P. falciparum from
fresh infection.
Acknowledgement
Author is grateful to Dr. Sarala K. Subbarao and Dr.
V.P. Sharma, former Directors of Malaria Research
Centre for their guidance, encouragement and support
for the study.  Author is also thankful to all fellow sci-
entists who have extended their support for the study.
Special thanks are also due to Dr. T. Adak, Deputy
Director for his help and co-operation.  Staff mem-
bers of Malaria Research Centre are gratefully ac-
knowledged for technical support.
References
1. Sharma VP. Current scenario of malaria in India. Parasi-
tologia 1999; 41 : 349–53.
2. Joshi H,  Subbarao Sarala K, Raghavendra K, Sharma VP.
Plasmodium vivax : enzyme polymorphism in isolates of
Indian origin.   Trans R Soc Trop Med Hyg  1989; 83 :
179–81.
3. Joshi H, Subbarao Sarala K,  Usha Devi C, Ghosh SK,
Biswas Sukla.  Isoenzyme variations and clonal composi-
tion in Indian isolates of Plasmodium falciparum.  J
Parasit Dis 1996; 20 : 137–40.
4. Joshi H, Subbarao Sarala K, Adak T, Nanda Nutan,
Ghosh SK, Carter R, Sharma VP.  Genetic structure of
Plasmodium vivax isolates in India.  Trans R Soc Trop
Med Hyg 1997; 91 : 231–5.
5. Biswas Sukla, Sharma Arun, Joshi Hema,  Misra Neerad
C, Valecha Neena, Kabilan Lalitha. Characteristics of
clones derived from Indian Plasmodium falciparum iso-
lates.  J Parasit Dis, 1996; 20(1) : 23–8.
6. Qari SH,  Ya-Ping Shi, Goldman IF, Udhayakumar V, Alp-
ers MP, Collins WE, Lal A.  Identification of P. vivax  like
human malaria parasite.  J Biol Chem 1991; 266 (25) :
16297–300.
7. Rosenberg Ronald, Rungsiwongse J, Kangsadalampai S,
Sattabongkot J, Suwanabun N, Chaiyaroj SC, Mongkol-
suk S.  Random mating of natural Plasmodium popula-
tions demonstrated from individual oocysts.  Mol Bio-
chem Parasitol 1992; 53 : 129–34.
8. Snewin VA, Khouri E, Wattavidanage J, Perera L, Prema-
vansa  S, Mendis KN, David TH.  A new polymorphic
marker for PCR typing of Plasmodium vivax parasites.
Mol Biochem Parasitol 1995; 71 : 135–8.
9. Bruce Marian C, Galinski Mary R, Barnwell John W,
Snounou Georges, Day Karen P.  Polymorphism at the
merozoite surface protein 3alpha locus of Plasmodium
vivax, global and local diversity. American J Trop Med
Hyg 1999; 61 (4) : 518–25.
10. Adak T, Sharma VP, Orlov VS.  Studies on P. vivax re-
lapse pattern in Delhi.   American J Trop Med Hyg 1998;
59 : 175–9.
11. Adak T, Valecha Neena, Sharma VP.  Plasmodium vivax
polymorphism in a clinical drug trial.  Clin Dign Lab Im-
mun 2001; 8 : 891–4.
12. Wooden J, Gould EE, Paull AT, Sibley CH.  Plasmodium fal-
ciparum  : a simple polymerase chain reaction method for
differentiating strains.  Expt Parasitol 1992; 75 : 207–12.
1.0 kb
500 bp
200 bp
1 23 4
1.0 kb
500 bp
200 bp
Fig. 6: Gel electrophoretogram showing genotyping of
paired samples : Pairs 1 & 3 with different size vari-
ants and pairs 2 & 4 are with same size variants of
MSP-1HEMA JOSHI :  GENETIC MARKERS OF HUMAN PLASMODIA 83
13. Ranford-Cartwright  LC, Taylor J, Umasunthar T, Taylor
LH, Babiker HA, Lell B, Schmidt-ott JR, Lehman LG,
Velliker D, Kermnser PG.  Molecular analysis of recrudes-
cent parasites in a P. falciparum drug efficacy trial in Ga-
bon. Trans R Soc Trop Med Hyg 1997; 91 : 719–24.
14. Snounou Georges, Zhu Xinping, Siripoon Napaporn, Jar-
ra William, Thaithong Sodsri, Brown K Neid, Viriyakosal
Suganya.  Biased distribution of MSP-1 and MSP-2 allel-
ic variants in Plasmodium falciparum populations in
Thailand.  Trans R Soc Trop Med Hyg 1999; 93 : 369–74.
15. Bhutani N, Ranjit MR, Yameen M, Singh Neeru, Dev Vas,
Pillai CR, Ansari MA, Sharma YD.  Genetic diversity
among field isolates of Plasmodium falciparum in India.
Curr Sci, 1998; 75 : 160–3.
16. Ranjit MR, Sharma YD.  Genetic polymorphism of falci-
parum malaria vaccine candidate antigen genes among
field isolates in India.  American J Trop Med Hyg 1999;
61(1) : 103–8.